Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-7 of 7 for your search:
Drug:
obatoclax mesylate
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
GEM012
, NCT00407303
2.
Phase I/II Study of Obatoclax Mesylate and Topotecan Hydrochloride in Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MSKCC-07082
, 07-082, 7937, NCT00521144
3.
Phase I/II Study of Obatoclax Mesylate and Bortezomib in Patients With Aggressive Relapsed or Recurrent Non-Hodgkin Lymphoma
Phase:
Phase II, Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Over 18
Sponsor:
NCI
Protocol IDs:
CCC-PHI-58
, PHI-58, 7943, NCT00538187
4.
Phase I/II Study of Obatoclax Mesylate and Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MAYO-MC068A
, MC068A, 7952, NCT00719901
5.
Obatoclax for Systemic Mastocytosis
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
2008-0792
, NCT00918931
6.
Phase I Study of Obatoclax Mesylate, Fludarabine Phosphate, and Rituximab in Patients With Previously Treated B-Cell Chronic Lymphocytic Leukemia
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
DFCI-07100
, 07-100, 7945, NCT00612612
7.
Phase I Study of Obatoclax Mesylate in Combination With Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Pediatric Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
6 months to 21 years
Sponsor:
NCI
Protocol IDs:
COG-ADVL0816
, ADVL0816, NCT00933985
Select All on Page
Help with Results
